Tech Company Financing Transactions
ENS Bio Funding Round
On 3/31/2006, ENS Bio raised $5.4 million in funding from Harris & Harris Group.
Transaction Overview
Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$5,375,000
Round
Undisclosed
Investors
Harris & Harris Group (Douglas Jamison)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
4 Colby St.
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Website
Email Address
Overview
Evolved Nanomaterial Sciences, Inc. is an emerging innovator in the field of chiral separations science. We have developed a number of unique and powerful technologies for the resolution of chiral molecules.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Pucciariello
Browse more venture capital transactions:
Prev: 3/31/2006: Entomo venture capital transaction
Next: 3/31/2006: Gigle Semiconductor venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs